Veriheal

MARCH 17, 2021

Fortunately, a group of trailblazers has found a way to impede (delay or prevent) cell growth in Glioblastoma patients. The team found that a cannabinoid known as CBG is the key to impeding the growth of glioblastoma cells, in turn extending life expectancy and reducing the effects of the condition. . What is CBG?

Research and Development 109

Research and Development Treatment Cannabinoids THC 109

United Patients Group

SEPTEMBER 7, 2023

As the perception of medical marijuana evolves and an increasing number of individuals explore its therapeutic potential, it’s crucial to develop a comprehensive understanding of cannabis’ impact on bodily systems. One area of interest and ongoing research is the relationship between cannabis and the immune system.

Research and Development 111

Research and Development Conditions Cannabinoids Patients 111

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis research problem. What makes a good research study, anyway?

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

FEBRUARY 1, 2022

New softgel capsule products further expand ZYUS’ medical cannabinoid offerings and provide patients a precise method for dosing. The launch of these two new softgel products marks another important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

Cannabinoids 52

Cannabinoids Patients Research and Development Media 52

Veriheal

SEPTEMBER 30, 2021

Cancer patients arguably stand to benefit the most from cannabis’ unique properties and benefits, such as anti-nausea, anti-inflammation, reduced pain, inhibited tumor growth, and appetite stimulation. Additionally, the increase in the availability of cannabis research has led to a decrease in stigmatization attached to cannabis.

Patients 98

Patients Research and Development Treatment Consumption 98

Cannabis Law Report

NOVEMBER 17, 2021

Launch of Zylem ™ 20:1 further expands ZYUS product offerings with new cannabinoid formulation. The launch of this formulation marks an important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential. About ZYUS Life Sciences Inc. Visit www.zyus.com.

Cannabinoids 52

Cannabinoids Patients Research and Development Extraction 52

Kind Meds (Cannabis Education Blog)

AUGUST 15, 2022

However, with the ongoing debate about the benefits and drawbacks of cannabinoids and other cannabis compounds , it can seem as if cannabis is an emerging trend. Cannabinoid Recognition. The medical field first began recognizing the benefits of the cannabinoid compounds within cannabis in 1850. What Are Cannabinoids?

Cannabinoids 52

Cannabinoids Research and Development Strains Sleep 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 109

Consumption Patients Research and Development Data 109

Veriheal

SEPTEMBER 18, 2020

Research Team to Study the Impact of CBD on Spinal Injury Pain. million of NWS Health funding for their Cannabinoid Therapeutics and Brain and Mind Centre to see if cannabidiol can be that effective treatment for spinal cord injury. Dr. Carins is a postdoctoral researcher who completed her Ph.D. Along with the $1.7

Treatment 98

Treatment Chronic Pain Research and Development CBD 98

MMJ Recs

JANUARY 2, 2024

As scientific research delves deeper into medical cannabis for cancer patients, MMJ’s potential has come to the forefront, offering new hope for individuals grappling with the complexities of cancer.

Treatment 98

Treatment Therapy Research and Development Patients 98

Cannabis Law Report

JULY 13, 2021

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].

Medicine 105

Medicine Research and Development Agriculture Strains 105

Veriheal

JANUARY 18, 2024

In a revolutionary development that reflects the ever-changing healthcare arena, cannabis nursing has earned official recognition as a specialized field in nursing. Patient education is their primary focus, as they provide knowledgeable guidance on the therapeutic benefits and potential risks of cannabis.

Education 113

Education Therapy Patients Research and Development 113

United Patients Group

SEPTEMBER 14, 2023

Medical cannabis has garnered tremendous attention and acceptance in recent years, with a growing body of research exploring its potential therapeutic benefits for a range of health conditions. Preliminary research also suggests it may have neuroprotective properties. To accomplish this, patients should: 1.

Terpenes 87

Terpenes Strains Research and Development Cannabinoids 87

CannaMD

NOVEMBER 4, 2020

According to a recent study published in the Journal of Headache Pain , across 2,032 patients and 21 illnesses, headache was a symptom treated with cannabis in 24.9% (505) of cases, while 88% (445) of headache patients treated probable migraines with cannabis. 30 percent of migraine patients in the U.S. Other Research Findings.

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

Cannabis Law Report

AUGUST 13, 2021

Instead, it is hypothesised that SalA indirectly influences the cannabinoid system, as well as being an allosteric modulator of the µ opioid receptor. Karl Hanes reported on 7 patients with TRD who described relief from depressive symptoms with continued oral consumption of salvia leaves three times a week. BERLIN, Aug.

Conditions 105

Conditions Research and Development Clinical Trials Treatment 105

MMJ Recs

APRIL 25, 2024

However, the production of medical cannabis involves a meticulous process to ensure quality, potency, and safety for patients. Utilizing nutrient-rich soil or hydroponic systems aids in supplying essential nutrients to the plants, fostering healthy development. Select seeds from reputable breeders known for producing stable genetics.

Marijuana 52

Marijuana Cultivation Trichome Safety 52

The Cannigma

FEBRUARY 18, 2021

While some traumatic brain injury (TBI) patients are able to make excellent recoveries, most would benefit from some kind of intervention that could help balance the body’s natural inflammatory response. Now, a research group at the Medical College of Georgia at Augusta University has been awarded a $1.8 Why, how, and when intervene?

Cannabinoids 40

Cannabinoids Research and Development Digestion Patients 40

Healer

JUNE 8, 2023

With cannabis and phytocannabinoids like THC, CBD and CBG rapidly becoming highly prized therapeutic agents, many people are turning to cannabinoids for life improvement. Unfortunately, there is a lot of misinformation that can be a stumbling block to those who could truly benefit from cannabinoids like CBD and THC.

Education 40

Education Cannabinoids Programs Research and Development 40

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. So, why did this educational gap develop? Unfortunately, this did not occur.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JULY 27, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., as its Research Director, a new role in the organization’s leadership. This study represents a refreshing collaboration of scientists, clinicians, patients and advocates.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Veriheal

NOVEMBER 13, 2020

Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). Many patients with OCD tend to perform actions without wanting to, but feeling powerless to try and stop it. What Does Research Say About Cannabis and OCD?

Research and Development 98

Research and Development Consumption Patients Strains 98

United Patients Group

DECEMBER 5, 2023

It’s a topic of serious conversation, vibrant debate, and ongoing research. Despite the controversy surrounding its legalization and use, there’s no denying the increasing amount of research supporting its therapeutic potential. One area of focus is its potential for treating mental health conditions.

Research and Development 94

Research and Development Treatment Patients Conditions 94

The Joint Blog

MARCH 18, 2021

According to a new study titled Use of cannabinoids for the treatment of patients with post-traumatic stress disorder, the consumption of cannabinoids and cannabinoid products is safe and effective in the mitigation of symptoms of post-traumatic stress (PTS).

Cannabinoids 26

Cannabinoids Patients Clinical Trials Research and Development 26

United Patients Group

OCTOBER 25, 2023

To address these concerns and provide clear, evidence-based answers to the most frequently asked questions about medical marijuana, we have compiled a comprehensive FAQ to help both patients and the general public make educated decisions about their healthcare options. What Conditions Can Medical Marijuana Treat?

Marijuana 88

Marijuana Patients Research and Development Edibles 88

Veriheal

AUGUST 16, 2021

The National Football League has taken proactive steps moving forward into the future with a research grant to explore potential therapeutic attributes of CBD, cannabis, and other options to treat pain other than opioids. NFL Research Grant Will Invest in a Bright Future for Athletes and Others. The opioid epidemic is real.

Therapy 104

Therapy Chronic Pain Research and Development Treatment 104

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

SpeedWeed

MARCH 24, 2021

A new study from the Department of Neuroscience at the Faculty of Health and Medical Sciences at the University of Copenhagen, published in Nature Neuroscience and titled “Spinal astroglial cannabinoid receptors control pathological tremor,” shows how cannabis could help those who suffer from pathological tremors. . The Study and Its Impact.

Cannabinoids 52

Cannabinoids Research and Development Treatment Conditions 52

SpeedWeed

JULY 23, 2021

Denver is expanding Alzheimer’s research through the efforts of local company MedPharm. . The company plans to move forward with research efforts through a special Schedule I Researcher Licenses given specifically to the company by the Drug Enforcement Administration. Denver Company Moves Forward with Research License .

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

Cannabis Law Report

JULY 28, 2021

This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Doctors prescribe various forms of opiods to cancer patients for pain.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Cannabis Law Report

JUNE 17, 2021

goodblend™ Texas , a retail brand of Parallel , one of the nation’s largest privately-held multi-state cannabis operators, today announced the launch of the first cannabinol (CBN) products for patients registered in the Texas Compassionate Use Program. goodblend™ Texas, a retail brand of Parallel.

Patients 97

Patients Programs Sleep Retail 97

Greencamp

AUGUST 25, 2018

Hence, lupus patients often look for complementary treatments for controlling their symptoms. It makes sense: The most common symptoms that patients with lupus have to deal with are inflammation and pain, and cannabis is known for being especially effective at fighting both. Approximately one in every 1000 Canadians has lupus and 1.5

Cannabinoids 92

Cannabinoids Strains Research and Development Sativa 92

United Patients Group

FEBRUARY 8, 2023

It’s no wonder that doctors are looking for new ways to treat patients with chronic pain without resorting to these highly addictive substances. Cannabinoids may have potential in treating chronic pain. Cannabinoids may have potential in treating chronic pain. Cannabinoids are the active compounds in cannabis.

Chronic Pain 81

Chronic Pain Cannabinoids Research and Development Patients 81

Puff Puff Post

JANUARY 13, 2020

Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. Generally speaking, 99 cent stores sell CBD that doesn’t have its terpenes or other cannabinoids measured. Preliminary Research on CBD Oil. Patients use whole CBD oil, instead of isolates.

CBD 52

CBD Clinical Trials Research and Development Oil 52